Blog - Page 3 of 5752 - QualityStocks

ThursdayOct 01, 2026 9:00 am

QualityStocksNewsBreaks – Lantern Pharma (NASDAQ: LTRN) Closes $4 Million Registered Direct Offering

Lantern Pharma (NASDAQ: LTRN), a clinical-stage, AI-native biopharma company using artificial intelligence and genomic data to develop precision oncology therapies, announced the closing of its previously announced registered direct offering of 3,669,725 shares of common stock, or pre-funded warrants in lieu thereof, at $1.09 per share. The offering generated approximately $4 million in gross proceeds before fees and expenses. In a concurrent private placement, Lantern issued unregistered warrants to purchase up to 3,669,725 shares at an exercise price of $1.09 per share, potentially providing an additional approximately $4 million in gross proceeds if fully exercised for cash. The company intends…

ThursdayOct 01, 2026 9:00 am

Greenland Mines Ltd. (NASDAQ: GRML) Management Outlines Pipeline, Path from Exploration to Production

Company president notes access to NA capital and finance experts, key management team and deep operational, logistical and technical expertise. The company's first project is Skaergaard, a deposit dominated by palladium and gold. Greenland Mines’ second project, Sarfartoq, targets neodymium and praseodymium, two rare earth elements used in powerful magnets. China mines more than two-thirds of the world's rare earth elements and processes up to 90% of them. That concentration concerns Western governments and manufacturers alike. Export controls from Beijing have already pushed up prices and disrupted supply chains for the magnets used in cars, wind turbines and defense systems.…

WednesdaySep 30, 2026 3:50 pm

QualityStocksNewsBreaks – Onco-Innovations Ltd. (CBOE CA: ONCO) (OTCQB: ONNVF) (FSE: W1H) Preps ONC010 for Clinical Translation

Disseminated on behalf of Onco-Innovations Ltd. (CBOE CA: ONCO) (OTCQB: ONNVF) (FSE: W1H) and may include paid advertising. Onco-Innovations (CBOE CA: ONCO)(OTCQB: ONNVF)(FSE: W1H) is advancing its preclinical oncology candidate ONC010, a nanoparticle-encapsulated PNKP inhibitor designed to disrupt DNA-repair mechanisms involved in cancer survival and treatment resistance, while building the manufacturing, regulatory and financial infrastructure needed for clinical development. The company reports completing a 300-gram API scale-up with approximately 99.3% purity, expanding manufacturing capabilities through a partnership with Nanosoft Polymers, and progressing metabolism, analytical, licensing and other IND-enabling activities. It has also arranged approximately CAD$5 million in institutional financing, to be released through 18 monthly tranches, to…

WednesdaySep 30, 2026 3:30 pm

QualityStocksNewsBreaks – Why SuperQ Quantum Computing Inc. (CSE: QBTQ) (OTCQB: QBTQF) (FSE: 25X) Is ‘One to Watch’

Disseminated on behalf of SuperQ Quantum Computing Inc. and may include paid advertisements. SuperQ Quantum (CSE: QBTQ) (OTCQB: QBTQF) (FSE: 25X) was featured in a recent article that discussed its focus on reducing the technical and financial barriers to commercial adoption of advanced computing. “The company combines quantum computing with classical high-performance computing to address complex optimization, cybersecurity and decision-making challenges for enterprises, governments and research institutions,” the publication reads. “SuperQ’s approach is centered on making advanced computational resources more accessible and commercially practical through an integrated ecosystem of software, hardware and AI-driven technologies. The company is developing solutions intended…

WednesdaySep 30, 2026 2:24 pm

QualityStocksNewsBreaks – TruGolf Holdings, Inc. (NASDAQ: TRUG) Announces First TruGolf Range Installation Featuring AI Coach

TruGolf (NASDAQ: TRUG) announced the first installation of its indoor range platform, TruGolf Range, featuring the company’s new TruGolf AI Coach experience at Lucid Golf in New Albany, Indiana. TruGolf Range allows up to five players to practice simultaneously on a single cinematic screen, with each hitting bay providing slow-motion replay of club and ball interaction, ball flight data and integrated AI analysis of swing tendencies. The Lucid Golf installation will include TruGolf AI Coach, which analyzes player shot data and tendencies to provide insights, instruction and drills. TruGolf Range also features structured training workflows, skills challenges and games and…

WednesdaySep 30, 2026 12:00 pm

Nano-X Imaging CEO and Directors Report Open-Market Share Purchases

Nano-X Imaging Ltd. (NASDAQ: NNOX) today announced that recent SEC Form 4 filings disclosed open-market purchases of the company's ordinary shares by Chief Executive Officer Erez Meltzer and Board Director Dan Suesskind. These purchases are in addition to other open-market purchases of Nano-X ordinary shares by company insiders including Erez Meltzer, Dan Suesskind and Board Director Nogah Keinan reported in recent months. Together, the purchases represent Nano-X ordinary shares acquired in the open market by the company's CEO and members of its Board of Directors. Additional information regarding the transactions is available in the respective SEC filings. About Nanox Nanox…

WednesdaySep 30, 2026 11:46 am

QualityStocksNewsBreaks – Alphabet Inc. (NASDAQ: GOOGL) (NASDAQ: GOOG) Shares Rise About 2% as Google Joins Voluntary AI Safety Accord

Alphabet (NASDAQ: GOOGL) (NASDAQ: GOOG) shares rose about 2% to $344.03 Wednesday morning as investors weighed Google’s participation in a voluntary AI safety accord, according to a GuruFocus article by Khac Phu Nguyen. The accord calls for internal controls, independent audits and safeguards intended to prevent AI systems from accessing technical infrastructure in unintended ways, while board committees would oversee audit findings. The article noted that the commitments remain voluntary and could provide greater policy clarity while adding compliance costs. GuruFocus said credible safeguards could help Google attract cloud customers handling sensitive information, though testing and audit requirements could increase…

WednesdaySep 30, 2026 11:15 am

Nightfood Holdings Inc. (NGTF) Writes the Next Chapter in Two Centuries of Hotel Technology

Hotel operations follow a long tradition of innovation and technology adoption. Each advance followed a similar logic: technology took on a burden, freeing people to focus on hospitality. That same approach is at the heart of TechForce Robotics’ portfolio. Every hotel guest who has tapped a card to open a door, ridden an elevator to a top floor or called the front desk from a room has benefited from technology that once seemed radical. The history of hospitality is also a history of practical innovation, and the next chapter may already be rolling quietly down hotel corridors. Nightfood Holdings, doing…

WednesdaySep 30, 2026 10:55 am

QualityStocksNewsBreaks – Perpetuals.com Ltd. (NASDAQ: PDC) to Present at AI & Technology Virtual Investor Conference Oct. 1

Perpetuals.com (NASDAQ: PDC) an AI-powered financial services company, announced that Chief Strategy Officer and Director Matthew Nicoletti will present live at the AI & Technology Virtual Investor Conference on Oct. 1, 2026. The interactive online event will allow investors to ask questions in real time, with an archived webcast available afterward. To view the full press release, visit https://ibn.fm/cYes5 About Perpetuals Perpetuals.com Ltd (NASDAQ: PDC) is a fintech company developing AI-powered trading products and prediction markets, with a global footprint across the United States, Europe, and Asia. Its mission is to reduce risk by empowering retail users with intuitive, secure,…

WednesdaySep 30, 2026 10:39 am

QualityStocksNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Co-Founder Discusses Lucid-MS Phase 2 Program, unbuzzd(TM) in BioMedWire Podcast

Quantum BioPharma (NASDAQ: QNTM) Co-Founder and Executive Co-Chair Anthony Durkacz returned to The BioMedWire Podcast to discuss the company’s Lucid-MS drug candidate, which is advancing to a Phase 2 trial in multiple sclerosis patients, as well as the development and commercial opportunity surrounding unbuzzd(TM). Durkacz said Lucid-MS targets myelin and that the upcoming trial will mark the first time the drug is tested in patients with multiple sclerosis. He also highlighted clinical results for unbuzzd(TM), which is designed to accelerate alcohol metabolism, and said Quantum BioPharma owns approximately 20% of the company behind the product and has a 7% royalty…

Site Search

Company Search